Authored by Felecia Dawson, MD, ABOG and Genester Wilson-King, MD, FACOG Edited by Jahan Marcu, PhD In October 2025, the American College of Obstetricians and Gynecologists updated its guidance on…
FOR IMMEDIATE RELEASE National Clinical Director Consortium Announces Strategic Merger with the Society of Cannabis Clinicians to Advance Clinical Excellence in Medical Cannabis Care Denver, Colorado, March 20, 2026: The…
FOR IMMEDIATE RELEASE Society of Cannabis Clinicians Announces Partnership with Whole Health Oncology Institute to Advance Patient-Reported Outcomes in Medical Cannabis Care Los Angeles, CA — February 24, 2026 —…
Policy Statement on Hemp Regulation and Public Health Society of Cannabis Clinicians (SCC) The Society of Cannabis Clinicians (“SCC”) is committed to advancing scientific understanding, clinical practice, and responsible policy…
The Society of Cannabis Clinicians (SCC) proudly announces its newly elected Executive Committee, marking a historic milestone in the organization’s 26-year history. For the first time, SCC is led by…
Cannabis and the Heart: A Clinical Interpretation of the Evidence Authored by the SCC Media Response Committee The relationship between cannabis and its impact on cardiovascular health has attracted growing…
Cannabis and the Heart: Clinicians Weigh in on Risks and Realities A new meta-analysis raises questions—clinicians weigh in on what we really know about cannabis and cardiovascular events. By: Jahan…
Jun 12, 2025 By Elisabeth Mack, MBA, BSN, RN & Member of the SCC Media Response Committee When Adult-Use Eclipses Medical: How Recreational Cannabis Legalization Has Undermined Patient Care Cannabis…
View full article here. A data driven response to “Aspergillus in Cannabis: Evaluating the Evidence and Crafting Sensible Policies”. Kevin McKernan, Sherman Hom, Ben Amirault, Yvonne Helbert, Steve McLaughlin, Liam…
Abstract In recent years, there has been heightened scrutiny of potential contaminants in cannabis, ranging from pesticides and chemical fertilizers to heavy metals and biological hazards. Among these, the presence…
Medicinal cannabis use is at an all-time high in the United States. From 2016 to 2020 alone, the number of patients enrolled in a state medical marijuana program quadrupled, according…
As the DEA proposes moving cannabis to Schedule III of the Controlled Substances Act, we enter a transformative period in the understanding and utilization of this complex botanical product. Moving…